Lab
Women's Healthcare Associates of Oakland PLLC
Women's Healthcare Associates of Oakland PLLC was paid $15.52M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 13% of everything it billed.
33Billing provider infoWOMEN'S HEALTHCARE ASSOCIATES OF OAKLAND PLLC
LAKE ORION, MI 48360
LAKE ORION, MI 48360
33aNPI1568653780assigned 08/05/2007
33bProvider typeClinical Medical Laboratory
28Total paid$15.52M
24GClaims224,159
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Michigan
Rank by total paid#10 of 108
Median peer was paid$588K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,166 | $1.82M | |
| 2019 | 29,959 | $2.07M | |
| 2020 | 33,222 | $2.23M | |
| 2021 | 38,539 | $2.90M | |
| 2022 | 36,377 | $2.68M | |
| 2023 | 33,316 | $2.14M | |
| 2024incomplete | 25,580 | $1.68M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 44,557 | 39,473 | $2.09M |
| 59426 | 12% | 2,204 | 2,197 | $1.85M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10.0% | 23,426 | 20,765 | $1.55M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 8.9% | 1,818 | 1,803 | $1.38M |
| 76830 | Ultrasound, transvaginal | 4.3% | 9,560 | 9,430 | $668K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 3.9% | 793 | 791 | $611K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.6% | 6,885 | 6,864 | $559K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.1% | 9,212 | 9,122 | $485K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 3.1% | 7,315 | 6,527 | $477K |
| 58558 | 3.0% | 1,035 | 1,020 | $462K | |
| 59430 | 2.8% | 2,184 | 2,168 | $434K | |
| 76818 | 2.5% | 5,543 | 2,738 | $382K |
59 more codes
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.1% | 3,254 | $332K |
| J9202 | Goserelin acetate implant, per 3.6 mg | 2.1% | 851 | $325K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.1% | 4,195 | $324K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 2.0% | 153 | $305K |
| 99203 | Doctor's office visit, new patient (routine) | 1.8% | 4,516 | $279K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.6% | 2,811 | $253K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.6% | 4,429 | $244K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.5% | 2,643 | $236K |
| 59514 | 1.4% | 247 | $211K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 7,129 | $192K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 1,979 | $187K |
| 76820 | 1.1% | 6,446 | $174K | |
| 99385 | <1% | 1,442 | $142K | |
| 59025 | Fetal non-stress test | <1% | 4,601 | $130K |
| 58662 | <1% | 505 | $124K | |
| 50715 | <1% | 178 | $117K | |
| 76801 | <1% | 1,647 | $116K | |
| 59425 | <1% | 254 | $115K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,983 | $91K |
| 81025 | <1% | 11,373 | $77K | |
| 54150 | <1% | 1,312 | $75K | |
| 58661 | <1% | 231 | $61K | |
| 76813 | <1% | 836 | $58K | |
| 58300 | <1% | 1,025 | $53K | |
| 11980 | <1% | 850 | $45K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 48 | $40K |
| 51700 | <1% | 854 | $35K | |
| 81002 | <1% | 13,567 | $34K | |
| 80305 | <1% | 4,122 | $33K | |
| 57454 | <1% | 372 | $32K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 383 | $29K |
| 99386 | <1% | 177 | $21K | |
| 58301 | <1% | 359 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 228 | $19K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 6,304 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 214 | $9K |
| 52000 | <1% | 229 | $8K | |
| 77080 | <1% | 173 | $4K | |
| 99283 | Emergency room visit (moderate) | <1% | 64 | $4K |
| 87210 | <1% | 738 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 81 | $2K |
| 96127 | <1% | 769 | $2K | |
| 51729 | <1% | 12 | $2K | |
| 51701 | <1% | 101 | $2K | |
| 99284 | Emergency room visit (serious) | <1% | 28 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 61 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 63 | $2K |
| 96161 | <1% | 1,564 | $2K | |
| 87481 | <1% | 27 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 298 | $859.66 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 16 | $842.84 |
| 51797 | <1% | 12 | $593.02 | |
| 46600 | <1% | 13 | $410.88 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 26 | $299.08 |
| 51784 | <1% | 12 | $220.42 | |
| 51741 | <1% | 12 | $50.13 | |
| 0502F | 0% | 3,980 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 333 | $0.00 |
| 0500F | 0% | 497 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZAIDAN, JONATHAN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Endometriosis Treatment Center of America - Michigan PLLC | Lake Orion, MI | $158K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.